Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Fitzgerald

Showing results (571-580 of 629) with videos related to

Pageof 63
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|March 21, 2021
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma RegistryEve Denton, David B Price, Trung N Tran, et al.
Respiratory Medicine|July 19, 2022
Disease burden in individuals with symptomatic undiagnosed asthma or COPDFatmah F Alhabeeb, G A Whitmore, Katherine L Vandemheen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitisWilliam W Busse, Jorge F Maspero, Yufang Lu, et al.
Canadian Respiratory Journal|July 16, 2004
Adult Asthma Consensus Guidelines update 2003Catherine Lemière, Tony Bai, Meyer Balter, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
The European Respiratory Journal|March 25, 2022
Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPDChau Huynh, G A Whitmore, Katherine L Vandemheen, et al.
American Journal of Respiratory and Critical Care Medicine|October 18, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled TrialsMalcolm Begg, J Nicole Hamblin, Emily Jarvis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 31, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Pageof 63

Showing results (571-580 of 629) with videos related to

Sort By:
Pageof 63
The Journal of Allergy and Clinical Immunology. in Practice|March 21, 2021
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma RegistryEve Denton, David B Price, Trung N Tran, et al.
Respiratory Medicine|July 19, 2022
Disease burden in individuals with symptomatic undiagnosed asthma or COPDFatmah F Alhabeeb, G A Whitmore, Katherine L Vandemheen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2022
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trialJienchi Dorward, Ly-Mee Yu, Gail Hayward, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 1, 2020
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitisWilliam W Busse, Jorge F Maspero, Yufang Lu, et al.
Canadian Respiratory Journal|July 16, 2004
Adult Asthma Consensus Guidelines update 2003Catherine Lemière, Tony Bai, Meyer Balter, et al.
The Lancet. Respiratory Medicine|July 30, 2021
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialChristopher C Butler, Ly-Mee Yu, Jienchi Dorward, et al.
The European Respiratory Journal|March 25, 2022
Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPDChau Huynh, G A Whitmore, Katherine L Vandemheen, et al.
American Journal of Respiratory and Critical Care Medicine|October 18, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
Exploring PI3Kδ Molecular Pathways in Stable COPD and Following an Acute Exacerbation, Two Randomized Controlled TrialsMalcolm Begg, J Nicole Hamblin, Emily Jarvis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 31, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Pageof 63